Fujiwara Himuro, Yamashita Chizuru, Kawaji Takahiro, Nakamura Tomoyuki, Kuriyama Naohide, Hara Yoshitaka, Komatsu Satoshi, Fukushima Minako, Suzuki Shinya, Tsutsumi Takaaki, Nishida Osamu
Department of Anesthesiology and Critical Care Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Fujita Med J. 2023 Aug;9(3):179-185. doi: 10.20407/fmj.2022-024. Epub 2022 Dec 27.
Perioperative venous thromboembolism (VTE) is a potentially fatal complication, making preoperative VTE diagnosis and secondary thromboprophylaxis important. This study was performed to investigate the impact of promotion of a preoperative VTE protocol at a perioperative management center (PMC) on detecting the preoperative VTE rate and subsequent treatment.
This retrospective study involved patients aged ≥20 years who underwent elective anesthesia. The patients were divided into two groups: the pre-PMC group (January to October 2014, before the opening of the PMC) and the post-PMC group (January to December 2019, after the opening of the PMC). The rates of preoperative lower-limb compression ultrasonography (CUS), VTE detection, anticoagulation therapy, and new postoperative pulmonary embolism (PE) were compared between the two groups.
The pre-PMC and post-PMC groups comprised 3737 and 5388 patients, respectively. The preoperative CUS and VTE detection rates were significantly higher in the post-PMC than pre-PMC group (7.2% and 1.43% vs. 25.6% and 3.93%, respectively; P<0.001). There was no significant difference in the rate of anticoagulation therapy in patients with preoperative VTE (88.9% vs. 84.7%, P=0.43). Heparin and direct oral anticoagulants were primarily used in the pre-PMC and post-PMC groups, respectively. The efficacy and safety were comparable between the two groups. No new postoperative PE was detected in either group.
Promotion of the preoperative VTE protocol led by the PMC increased the rates of preoperative CUS and preoperative VTE detection. This may aid in secondary thromboprophylaxis in the preoperative period and prevention of postoperative PE.
围手术期静脉血栓栓塞症(VTE)是一种潜在的致命并发症,因此术前VTE诊断和二级血栓预防很重要。本研究旨在调查围手术期管理中心(PMC)推行术前VTE方案对术前VTE检出率及后续治疗的影响。
本回顾性研究纳入年龄≥20岁接受择期麻醉的患者。患者分为两组:PMC成立前组(2014年1月至10月,PMC开业前)和PMC成立后组(2019年1月至12月,PMC开业后)。比较两组术前下肢加压超声检查(CUS)、VTE检出率、抗凝治疗率及术后新发肺栓塞(PE)的发生率。
PMC成立前组和成立后组分别有3737例和5388例患者。PMC成立后组术前CUS和VTE检出率显著高于成立前组(分别为7.2%和1.43% vs. 25.6%和3.93%;P<0.001)。术前VTE患者的抗凝治疗率无显著差异(88.9% vs. 84.7%,P=0.43)。PMC成立前组和成立后组分别主要使用肝素和直接口服抗凝剂。两组的疗效和安全性相当。两组均未检测到术后新发PE。
PMC主导推行术前VTE方案提高了术前CUS和术前VTE检出率。这可能有助于术前二级血栓预防及预防术后PE。